185 related articles for article (PubMed ID: 35171534)
21. RAS mutation status in combination with the JSHBPS nomogram may be useful for preoperative identification of colorectal liver metastases with high risk of recurrence and mortality after hepatectomy.
Takematsu T; Mima K; Hayashi H; Kitano Y; Nakagawa S; Hiyoshi Y; Okabe H; Imai K; Miyamoto Y; Baba H
J Hepatobiliary Pancreat Sci; 2024 Feb; 31(2):69-79. PubMed ID: 37897144
[TBL] [Abstract][Full Text] [Related]
22. Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases.
Margonis GA; Sasaki K; Kim Y; Samaha M; Buettner S; Amini N; Antoniou E; Pawlik TM
J Gastrointest Surg; 2016 Nov; 20(11):1821-1829. PubMed ID: 27384430
[TBL] [Abstract][Full Text] [Related]
23. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Vauthey JN; Zimmitti G; Kopetz SE; Shindoh J; Chen SS; Andreou A; Curley SA; Aloia TA; Maru DM
Ann Surg; 2013 Oct; 258(4):619-26; discussion 626-7. PubMed ID: 24018645
[TBL] [Abstract][Full Text] [Related]
24. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.
Creasy JM; Sadot E; Koerkamp BG; Chou JF; Gonen M; Kemeny NE; Saltz LB; Balachandran VP; Peter Kingham T; DeMatteo RP; Allen PJ; Jarnagin WR; D'Angelica MI
Ann Surg Oncol; 2018 Feb; 25(2):431-438. PubMed ID: 29181680
[TBL] [Abstract][Full Text] [Related]
26. Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials.
Tejpar S; Stintzing S; Ciardiello F; Tabernero J; Van Cutsem E; Beier F; Esser R; Lenz HJ; Heinemann V
JAMA Oncol; 2017 Feb; 3(2):194-201. PubMed ID: 27722750
[TBL] [Abstract][Full Text] [Related]
27. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
[TBL] [Abstract][Full Text] [Related]
28. RAS/TP53 Co-mutation is Associated With Worse Survival After Concurrent Resection of Colorectal Liver Metastases and Extrahepatic Disease.
Lillemoe HA; Passot G; Kawaguchi Y; DeBellis M; Glehen O; Chun YS; Tzeng CD; Aloia TA; Lopez J; Vauthey JN
Ann Surg; 2022 Aug; 276(2):357-362. PubMed ID: 33351476
[TBL] [Abstract][Full Text] [Related]
29. Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver Metastasis.
Chen TH; Chen WS; Jiang JK; Yang SH; Wang HS; Chang SC; Lan YT; Lin CC; Lin HH; Huang SC; Cheng HH; Chau GY; Hsia CY; Lei HJ; Chou SC; Chao Y; Teng HW
J Gastrointest Surg; 2021 Mar; 25(3):650-661. PubMed ID: 33201458
[TBL] [Abstract][Full Text] [Related]
30. Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
Margonis GA; Buettner S; Andreatos N; Sasaki K; Ijzermans JNM; van Vugt JLA; Pawlik TM; Choti MA; Cameron JL; He J; Wolfgang CL; Weiss MJ
Ann Surg; 2017 Oct; 266(4):641-649. PubMed ID: 28657938
[TBL] [Abstract][Full Text] [Related]
31. Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases.
Xu D; Wang HW; Yan XL; Li J; Wang K; Xing BC
Eur J Surg Oncol; 2019 Sep; 45(9):1551-1558. PubMed ID: 30879931
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis.
Moro A; Mehta R; Tsilimigras DI; Sahara K; Paredes AZ; Bagante F; Guglielmi A; Alexandrescu S; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
Surgery; 2020 Sep; 168(3):497-503. PubMed ID: 32675031
[TBL] [Abstract][Full Text] [Related]
33. Reevaluating the prognostic value of RAS mutation status in patients with resected liver metastases from colorectal cancer: A systematic review and meta-analysis.
Pikoulis E; Papaconstantinou D; Pikouli A; Wang J; Theodoridis C; Margonis GA
J Hepatobiliary Pancreat Sci; 2021 Aug; 28(8):637-647. PubMed ID: 34115442
[TBL] [Abstract][Full Text] [Related]
34. RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.
Brudvik KW; Jones RP; Giuliante F; Shindoh J; Passot G; Chung MH; Song J; Li L; Dagenborg VJ; Fretland ÅA; Røsok B; De Rose AM; Ardito F; Edwin B; Panettieri E; Larocca LM; Yamashita S; Conrad C; Aloia TA; Poston GJ; Bjørnbeth BA; Vauthey JN
Ann Surg; 2019 Jan; 269(1):120-126. PubMed ID: 28549012
[TBL] [Abstract][Full Text] [Related]
35. Impact of Age of Onset on Survival after Hepatectomy for Patients with Colorectal Cancer Liver Metastasis: A Real-World Single-Center Experience.
Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Ge SK; Wang K; Xing BC
Curr Oncol; 2022 Nov; 29(11):8456-8467. PubMed ID: 36354726
[TBL] [Abstract][Full Text] [Related]
36. RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases.
Denbo JW; Yamashita S; Passot G; Egger M; Chun YS; Kopetz SE; Maru D; Brudvik KW; Wei SH; Conrad C; Vauthey JN; Aloia TA
J Gastrointest Surg; 2017 Jan; 21(1):68-77. PubMed ID: 27334313
[TBL] [Abstract][Full Text] [Related]
37. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
Mizuno T; Cloyd JM; Vicente D; Omichi K; Chun YS; Kopetz SE; Maru D; Conrad C; Tzeng CD; Wei SH; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2018 May; 44(5):684-692. PubMed ID: 29551247
[TBL] [Abstract][Full Text] [Related]
38. Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.
Saadat LV; Boerner T; Goldman DA; Gonen M; Frankel TL; Vakiani E; Kingham TP; Jarnagin WR; Wei AC; Soares KC; Solit DB; D'Angelica MI
Ann Surg Oncol; 2021 Feb; 28(2):817-825. PubMed ID: 32683635
[TBL] [Abstract][Full Text] [Related]
39. Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected.
Sastre J; Orden V; Martínez A; Bando I; Balbín M; Bellosillo B; Palanca S; Peligros Gomez MI; Mediero B; Llovet P; Moral VM; Viéitez JM; García-Alfonso P; Calle SG; Ortiz-Morales MJ; Salud A; Quintero G; Lopez C; Díaz-Rubio E; Aranda E;
Clin Colorectal Cancer; 2020 Sep; 19(3):e110-e116. PubMed ID: 32278676
[TBL] [Abstract][Full Text] [Related]
40. APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases.
Yamashita S; Chun YS; Kopetz SE; Maru D; Conrad C; Aloia TA; Vauthey JN
Ann Surg; 2020 Dec; 272(6):1080-1085. PubMed ID: 28379870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
